On December 11th, 2023, Keran Pharmaceuticals moved to a new house in No. 88 Shangke Road, Pudong, Shanghai. With more complete laboratory space and more comfortable office environment, Keran Pharma has started a new chapter with a brand new outlook.
Recently, Cholesgen (Shanghai) Co. Ltd. has completed its Series A financing of over RMB 100 million, which was led by Gaorong Ventures, with participation from Great Filter Venture, Leading Capital, and AstraZeneca-CICC Capital, as well as investment from angel investors, Trinity Fund. The company will utilize the financing to accelerate the development of its core innovative drug pipeline, expand its R&D team, and expand external collaborations and office space.
珂闌微信公眾號
Copyright ?? 2023 珂闌（上海）醫藥科技有限公司 . 滬ICP備2021011521號-1
滬公網安備31011502401884
DESIGN BY： YUSHANG WEB